首页> 外文期刊>Journal of International Medical Research >Effect-site concentration of remifentanil required to blunt haemodynamic responses during tracheal intubation: A randomized comparison between single- and double-lumen tubes
【24h】

Effect-site concentration of remifentanil required to blunt haemodynamic responses during tracheal intubation: A randomized comparison between single- and double-lumen tubes

机译:气管插管过程中钝化血流动力学反应所需的瑞芬太尼作用部位浓度:单腔管和双腔管的随机比较

获取原文
           

摘要

Objective To investigate the effect-site concentration of remifentanil required to blunt haemodynamic responses during tracheal intubation with a single-lumen tube (SLT) or a double-lumen tube (DLT). Methods Patients scheduled for thoracic surgery requiring one-lung ventilation were randomly allocated to either the SLT or DLT group. All patients received a target-controlled infusion of propofol and a predetermined concentration of remifentanil. Haemodynamic parameters during intubation were recorded. The effect-site concentration of remifentanil was determined using a delayed up-and-down sequential allocation method. Results A total of 92 patients were enrolled in the study. The effective effect-site concentrations of remifentanil required to blunt haemodynamic responses in 50% of patients (EC_(50)) estimated by isotonic regression with bootstrapping was higher in the DLT than the SLT group (8.5?ng/ml [95% confidence interval (CI) 8.0–9.5?ng/ml] versus 6.5?ng/ml [95% CI 5.6–6.7?ng/ml], respectively). Similarly, the effective effect-site concentrations of remifentanil in 95% of patients in the DLT group was higher than the SLT group (9.9?ng/ml [95% CI 9.8–10.0?ng/ml] versus 7.0?ng/ml [95% CI 6.9–7.0?ng/ml], respectively). Conclusions This study demonstrated that a DLT requires a 30% higher EC_(50)of remifentanil than does an SLT to blunt haemodynamic responses during tracheal intubation when combined with a target-controlled infusion of propofol. Trial registration Clinicaltrials.gov identifier: NCT01542099.
机译:目的研究单腔管(SLT)或双腔管(DLT)气管插管时钝化血液动力学反应所需的瑞芬太尼的作用部位浓度。方法将计划进行单肺通气的胸外科患者随机分为SLT组或DLT组。所有患者均接受靶控输注的异丙酚和预定浓度的瑞芬太尼。记录插管过程中的血流动力学参数。使用延迟的上下顺序分配方法确定瑞芬太尼的作用部位浓度。结果共纳入92例患者。通过等张回归和自举法估计的50%患者(EC_(50))钝化血流动力学反应所需的瑞芬太尼的有效作用部位浓度在DLT中高于SLT组(8.5?ng / ml [95%置信区间(CI)8.0-9.5 ng / ml]和6.5 ng / ml [95%CI 5.6-6.7 ng / ml]。同样,DLT组中95%的患者的瑞芬太尼的有效作用部位浓度高于SLT组(9.9?ng / ml [95%CI 9.8-10.0?ng / ml]与7.0?ng / ml [分别为95%CI 6.9–7.0?ng / ml]。结论这项研究表明,与靶控输注异丙酚相结合时,在气管插管过程中DLT要求的瑞芬太尼EC_(50)比SLT高30%,以钝化血液动力学反应。试用注册Clinicaltrials.gov标识符:NCT01542099。

著录项

相似文献

  • 外文文献
  • 中文文献
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号